MIVALSECOVATEIN
UNII 9NLL7B5W2N

Substance Identification & Data

This profile provides standardized clinical and technical data for Mivalsecovatein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9NLL7B5W2N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2928522-52-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9NLL7B5W2N

CAS Registry Number

2928522-52-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIVALSECOVATEIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211751

National Cancer Institute reference terminology for clinical and research data.

INN ID

13294

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mivalsecovatein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIVALSECOVATEIN

Common Names & Synonyms

MIVALSECOVATEIN [INN]

VIRAL SPIKE GLYCOPROTEIN NVX-COV2601 (665-GLUTAMINE,666-GLUTAMINE,668-GLUTAMINE,968-PROLINE,969-PROLINE) (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VARIANT XBB.1.5)

Technical Codes

NVX-COV2601

External Clinical & Regulatory Resources

Previous UNII9NL385N34R

Next UNII9NLU6H3LRD